Nomura Holdings’s Kura Oncology KURA Stock Holding History

Nomura Holdings’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,985	Closed	-$122K	–	1942
2026 Q1	$122K	Sell	14,985 -18,589	-55%	-$160K	﹤0.01%	1613
2025 Q4	$349K	Buy	+33,574	New	+$352K	﹤0.01%	1632

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Nomura Holdings's KURA Position: Q2 2026 in Review

Nomura Holdings sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 14,985 shares — an estimated $122K sold.

Nomura Holdings first reported a position in KURA in Q4 2025 and held it in 2 quarters. The position peaked at $349K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Nomura Holdings reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
Nomura Holdings sold 14,985 Kura Oncology shares in Q2 2026, an estimated $122K.
Nomura Holdings first reported a position in Kura Oncology in Q4 2025 and held it in 2 quarters.
Nomura Holdings's Kura Oncology position peaked at $349K in Q4 2025.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.